Blood Draw Study for Liver Transplant Patients

NCT01525797 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 221

Last updated 2026-01-26

No results posted yet for this study

Summary

The purpose of this study is to see what a lab test will show and if there is a way to predict which patients will be more likely to have rejection after receiving a liver transplant.

Conditions

  • Liver Transplant Recipients

Sponsors & Collaborators

  • Baylor Research Institute

    lead OTHER

Principal Investigators

  • Goran Klintmalm, MD · Baylor Health Care System

Eligibility

Min Age
17 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2002-10-15
Primary Completion
2013-10-04
Completion
2013-10-04

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01525797 on ClinicalTrials.gov